MeSH Review:
Rheumatology
McAlindon,
LaValley,
Gulin,
Felson,
Edworthy,
Dobkin,
Clarke,
Da Costa,
Dritsa,
Fortin,
Barr,
Ensworth,
Esdaile,
Beaulieu,
Zummer,
Senécal,
Goulet,
Choquette,
Rich,
Smith,
Cividino,
Gladman,
Devins,
Padyukov,
Lampa,
Heimbürger,
Ernestam,
Cederholm,
Lundkvist,
Andersson,
Hermansson,
Harju,
Klareskog,
Bratt,
O'Dell,
Blakely,
Mallek,
Eckhoff,
Leff,
Wees,
Sems,
Fernandez,
Palmer,
Klassen,
Paulsen,
Haire,
Moore,
Sladek,
Pinnock,
Phillips,
Kaltwasser,
Nash,
Gladman,
Rosen,
Behrens,
Jones,
Wollenhaupt,
Falk,
Mease,
Schnitzer,
Karlson,
Liang,
Eaton,
Huang,
Fitzgerald,
Rogers,
Daltroy,
Tanaka,
Saito,
Kamitsuji,
Yamada,
Nakajima,
Taniguchi,
Hara,
Tomatsu,
Yamanaka,
Kamatani,
Stamm,
Cieza,
Machold,
Smolen,
Stucki,
- Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Duits, A.J., Bootsma, H., Derksen, R.H., Spronk, P.E., Kater, L., Kallenberg, C.G., Capel, P.J., Westerdaal, N.A., Spierenburg, G.T., Gmelig-Meyling, F.H. Arthritis Rheum. (1995)
- Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip.American College of Rheumatology. Hochberg, M.C., Altman, R.D., Brandt, K.D., Clark, B.M., Dieppe, P.A., Griffin, M.R., Moskowitz, R.W., Schnitzer, T.J. Arthritis Rheum. (1995)
- Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Kremer, J.M., Alarcón, G.S., Lightfoot, R.W., Willkens, R.F., Furst, D.E., Williams, H.J., Dent, P.B., Weinblatt, M.E. Arthritis Rheum. (1994)
- Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Kaltwasser, J.P., Nash, P., Gladman, D., Rosen, C.F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F.G., Mease, P. Arthritis Rheum. (2004)
- Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Walker, A.M., Funch, D., Dreyer, N.A., Tolman, K.G., Kremer, J.M., Alarcón, G.S., Lee, R.G., Weinblatt, M.E. Arthritis Rheum. (1993)
- Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index. Engle, E.W., Callahan, L.F., Pincus, T., Hochberg, M.C. Arthritis Rheum. (1990)
- Physical activity as a determinant of bone conservation in the radial diaphysis in rheumatoid arthritis. Shawe, D., Hesp, R., Gumpel, J.M., Sambrook, P.N., Reeve, J. Ann. Rheum. Dis. (1993)
- Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus. Edworthy, S.M., Dobkin, P.L., Clarke, A.E., Da Costa, D., Dritsa, M., Fortin, P.R., Barr, S., Ensworth, S., Esdaile, J.M., Beaulieu, A., Zummer, M., Senécal, J.L., Goulet, J.R., Choquette, D., Rich, E., Smith, D., Cividino, A., Gladman, D., Devins, G.M. J. Rheumatol. (2003)
- The informationist: a prospective uncontrolled study. Sladek, R.M., Pinnock, C., Phillips, P.A. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua. (2004)
- Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. Lovell, D.J., Giannini, E.H., Reiff, A., Cawkwell, G.D., Silverman, E.D., Nocton, J.J., Stein, L.D., Gedalia, A., Ilowite, N.T., Wallace, C.A., Whitmore, J., Finck, B.K. N. Engl. J. Med. (2000)
- A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. Bathon, J.M., Martin, R.W., Fleischmann, R.M., Tesser, J.R., Schiff, M.H., Keystone, E.C., Genovese, M.C., Wasko, M.C., Moreland, L.W., Weaver, A.L., Markenson, J., Finck, B.K. N. Engl. J. Med. (2000)
- A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. Weinblatt, M.E., Kremer, J.M., Bankhurst, A.D., Bulpitt, K.J., Fleischmann, R.M., Fox, R.I., Jackson, C.G., Lange, M., Burge, D.J. N. Engl. J. Med. (1999)
- Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. Tugwell, P., Pincus, T., Yocum, D., Stein, M., Gluck, O., Kraag, G., McKendry, R., Tesser, J., Baker, P., Wells, G. N. Engl. J. Med. (1995)
- Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. McAlindon, T.E., LaValley, M.P., Gulin, J.P., Felson, D.T. JAMA (2000)
- Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Falaschi, F., Ravelli, A., Martignoni, A., Migliavacca, D., Sartori, M., Pistorio, A., Perani, G., Martini, A. Arthritis Rheum. (2000)
- Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Chen, M., Yu, F., Zhang, Y., Zou, W.Z., Zhao, M.H., Wang, H.Y. Kidney Int. (2005)
- Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis. Morand, E.F., McCloud, P.I., Littlejohn, G.O. Ann. Rheum. Dis. (1992)
- Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Gaber, T., Dziurla, R., Tripmacher, R., Burmester, G.R., Buttgereit, F. Ann. Rheum. Dis. (2005)
- Screening for proteinuria in a rheumatology clinic: comparison of dipstick testing, 24 hour urine quantitative protein, and protein/creatinine ratio in random urine samples. Ralston, S.H., Caine, N., Richards, I., O'Reilly, D., Sturrock, R.D., Capell, H.A. Ann. Rheum. Dis. (1988)
- Content comparison of occupation-based instruments in adult rheumatology and musculoskeletal rehabilitation based on the International Classification of Functioning, Disability and Health. Stamm, T.A., Cieza, A., Machold, K.P., Smolen, J.S., Stucki, G. Arthritis Rheum. (2004)
- Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Gough, A., Faint, J., Salmon, M., Hassell, A., Wordsworth, P., Pilling, D., Birley, A., Emery, P. Arthritis Rheum. (1994)
- Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. MacKay, K., Milicic, A., Lee, D., Tikly, M., Laval, S., Shatford, J., Wordsworth, P. Rheumatology (Oxford, England) (2003)
- Chloroquine retinopathy: is there a safe daily dose? Marks, J.S. Ann. Rheum. Dis. (1982)
- Treatment of dermatomyositis with methotrexate. Zieglschmid-Adams, M.E., Pandya, A.G., Cohen, S.B., Sontheimer, R.D. J. Am. Acad. Dermatol. (1995)
- Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Tanaka, E., Saito, A., Kamitsuji, S., Yamada, T., Nakajima, A., Taniguchi, A., Hara, M., Tomatsu, T., Yamanaka, H., Kamatani, N. Arthritis Rheum. (2005)
- Longterm outcome of treatment of Felty's syndrome with intramuscular gold: case reports and recommendations for management. Almoallim, H., Klinkhoff, A. J. Rheumatol. (2005)
- Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Vilá, L.M., Mayor, A.M., Valentín, A.H., García-Soberal, M., Vilá, S. Lupus (2000)
- Translation into Brazilian Portuguese, cultural adaptation and evaluation of the reliability of the Disabilities of the Arm, Shoulder and Hand Questionnaire. Orfale, A.G., Araújo, P.M., Ferraz, M.B., Natour, J. Braz. J. Med. Biol. Res. (2005)
- Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. Giannini, E.H., Brewer, E.J., Kuzmina, N., Shaikov, A., Maximov, A., Vorontsov, I., Fink, C.W., Newman, A.J., Cassidy, J.T., Zemel, L.S. N. Engl. J. Med. (1992)
- The American Board of Internal Medicine recertification program in rheumatology. Johanson, W.G., Moskowitz, R.W., Langdon, L.O. Arthritis Rheum. (1995)
- Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. O'Dell, J.R., Paulsen, G., Haire, C.E., Blakely, K., Palmer, W., Wees, S., Eckhoff, P.J., Klassen, L.W., Churchill, M., Doud, D., Weaver, A., Moore, G.F. Arthritis Rheum. (1999)
- Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Weinblatt, M.E., Kremer, J.M., Coblyn, J.S., Maier, A.L., Helfgott, S.M., Morrell, M., Byrne, V.M., Kaymakcian, M.V., Strand, V. Arthritis Rheum. (1999)
- Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. O'Dell, J.R., Blakely, K.W., Mallek, J.A., Eckhoff, P.J., Leff, R.D., Wees, S.J., Sems, K.M., Fernandez, A.M., Palmer, W.R., Klassen, L.W., Paulsen, G.A., Haire, C.E., Moore, G.F. Arthritis Rheum. (2001)
- Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Kraan, M.C., Reece, R.J., Barg, E.C., Smeets, T.J., Farnell, J., Rosenburg, R., Veale, D.J., Breedveld, F.C., Emery, P., Tak, P.P. Arthritis Rheum. (2000)
- Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Padyukov, L., Lampa, J., Heimbürger, M., Ernestam, S., Cederholm, T., Lundkvist, I., Andersson, P., Hermansson, Y., Harju, A., Klareskog, L., Bratt, J. Ann. Rheum. Dis. (2003)
- Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitors. Schnitzer, T.J. Clinical therapeutics. (2001)
- Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Crnkic, M., Månsson, B., Larsson, L., Geborek, P., Heinegård, D., Saxne, T. Arthritis Res. Ther. (2003)
- Traditional and new types of spondarthritis with special consideration of spondylodiscitis. Schilling, F., Stollenwerk, R., Dreher, R. Neurosurgical review. (1990)
- Validity and reliability of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus: comment on the article by Kozora et al. Hietaharju, A., Auvinen, A. Arthritis Rheum. (2005)
- A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Karlson, E.W., Liang, M.H., Eaton, H., Huang, J., Fitzgerald, L., Rogers, M.P., Daltroy, L.H. Arthritis Rheum. (2004)
- Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Hidaka, T., Suzuki, K., Matsuki, Y., Takamizawa-Matsumoto, M., Kataharada, K., Ishizuka, T., Kawakami, M., Nakamura, H. Arthritis Rheum. (1999)
- Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Chiang, E.P., Bagley, P.J., Selhub, J., Nadeau, M., Roubenoff, R. Am. J. Med. (2003)
- The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Berube, C., Mitchell, L., Silverman, E., David, M., Saint Cyr, C., Laxer, R., Adams, M., Vegh, P., Andrew, M. Pediatr. Res. (1998)